Ashkenazi Jewish Origin Protects Against Formation of Antibodies to Infliximab and Therapy Failure

Infliximab is an anti-tumor necrosis factor (TNF) used for treatment of inflammatory bowel disease (IBD) as well as rheumatoid arthritis, psoriasis, and other inflammatory conditions. Antibodies to infliximab (ATI) develop in approximately 45% of infliximab-treated IBD patients and are correlated wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ungar, Bella, Haj-Natour, Ola, Kopylov, Uri, Yavzori, Miri, Fudim, Ella, Picard, Orit, Loebstein, Ronen, Lahat, Adi, Maor, Yaakov, Avidan, Benjamin, Lang, Alon, Weiss, Batia, Chowers, Yehuda, Eliakim, Rami, Ben-Horin, Shomron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602524/
https://www.ncbi.nlm.nih.gov/pubmed/25950682
http://dx.doi.org/10.1097/MD.0000000000000673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602524/
https://www.ncbi.nlm.nih.gov/pubmed/25950682
http://dx.doi.org/10.1097/MD.0000000000000673

Ejemplares similares